Charles River Laboratories | CRL - Interest Income


Charles River Laboratories reported $-0.3 in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Agilent USD 15M 2M Dec/2025
Align Technology USD 4.62M 1.37M Dec/2025
Bio-Rad Laboratories USD 31M 17.3M Dec/2025
Bruker USD 4.4M 1.5M Sep/2025
Charles River Laboratories USD -0.3 1.02M Mar/2026
Concord Medical Services Hldg CNY 5.8M 659K Jun/2023
Danaher USD 27M 14M Mar/2026
Dentsply International USD 4M 1000K Mar/2025
Illumina USD 0.87 10M Mar/2026
Incyte USD 33.69M 2.93M Mar/2026
Intrexon USD 319K 602K Jun/2024
IQVIA Holdings USD 10M 1000K Mar/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 21M 6M Dec/2025
Pfizer USD 115M 51M Mar/2026
Quest Diagnostics USD 2M 1000K Mar/2026
Revvity USD 5.75M 5.75M Dec/2025
Thermo Fisher Scientific USD 258M 258M Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025
Veradigm USD 1.7M 1.6M Sep/2022
Waters USD 5.67M 5.67M Dec/2025
West Pharmaceutical Services USD 5.1M 400K Dec/2025